Johnson Matthey sells Medical Device Components business for US$700 million to Montagu
The MDC business produces components for medical device manufacturers globally with a focus on precious metal alloys and nitinol
The MDC business produces components for medical device manufacturers globally with a focus on precious metal alloys and nitinol
Winlevi is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older
Clinical findings support the safety and efficacy of BMND08 at a maximum dosage of 12mg
The overall transaction is expected to conclude over next 12-15 months subject to receipt of all relevant shareholder and regulatory approvals
The objective of GCMC is well aligned to WHO’s call to action and India’s National Biotechnology Development Strategy
Net product sales in the fourth quarter of 2023 include the recognition of $0.6 billion from deferred revenue, related to Gavi, the Vaccine Alliance
Pelabresib recently met its primary endpoint of spleen volume reduction and demonstrated favorable trends in symptom improvement
JPL plans to sell its entire 25.8% equity stake in Sofie for aggregate proceeds of about US$ 139.43 million
For 9 months period ended December 2023, the company’s PAT up 16% to Rs 330 crores (before exceptional items)
Synthon will be responsible for obtaining US regulatory approval for Palbociclib Tablets
Subscribe To Our Newsletter & Stay Updated